Technology & Software Global On demand · 24-48h

Global Surgical Planning Software Market Strategic Research Report

Name: Global Surgical Planning Software Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Surgical Planning Software Market Strategic Research …

$3,500 USD

Strategic Research Report

Global Surgical Planning Software Market

$1392025

6.3%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Pre-operative, Post-operative

By Application: Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Stryker, Zimmer Biomet, DePuy Synthes, Materialise, Brainlab AG, Synopsys, medicAD Hectec GmbH, DePLy Synthes(Johnson &Johnson Medical Devices Companies), CANONMEDICAL SISTEMSUSA INC, GeneralElectric Company, Renishaw Plc, WishBone Medical, EchoPixel, Intrasense, Siemens, Koninklijke Philips, RaySearch Laboratories, Renishaw, Brainlab, Elekta, inomed Medizintechnik, Neurostar, Micromar

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 151 pages

Market size 2025

$139

Million USD

Forecast CAGR

6.3%

2025-2032

Forecast 2032

$213.2

Projected

リージョン

Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Surgical Planning Software market size is predicted to grow from US$ 139 million in 2025 to US$ 212 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Surgical Planning Software is a medical technology tool that integrates medical image analysis, 3D modeling, and intelligent algorithms. It aims to digitally assist surgeons in preoperative planning and risk assessment. Its core functions include converting a patient's 2D imaging data, such as CT and MRI, into a 3D anatomical model. It then integrates surgical simulation and path optimization techniques to provide precise support for clinical decision-making.

As personalized medicine becomes more prevalent, doctors need to tailor surgical plans to the patient's specific anatomy and condition. Surgical planning software, which meets this need, is seeing increasing demand.

The increasing global aging population is leading to a surge in demand for procedures such as orthopedics and neurosurgery. For example, the American Academy of Orthopedic Surgeons reported that over 1.7 million hip and knee replacements were performed in 2020, driving the surgical planning software market.

The integration of AI and machine learning technologies enables surgical planning software to perform real-time analysis and predictive outcome modeling. The rise of cloud platforms facilitates seamless collaboration among multidisciplinary teams, while AR and VR technologies enhance preoperative planning and surgical education.

This report presents a comprehensive overview of the global Surgical Planning Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Pre-operative
Post-operative

Segment by Application

Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Surgical Planning Software market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs) evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Surgical Planning Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 6.3%

Regional growth momentum

Market share by segment

Key metrics

Base value

$139

2025

Forecast

$213.2

2032

CAGR

6.3%

2025–2032

リージョン

global

Key companies

StrykerZimmer BiometDePuy SynthesMaterialiseBrainlab AGSynopsysmedicAD Hectec GmbHDePLy Synthes(Johnson &Johnson Medical Devices Companies)

Segments covered in this report

By Type

Pre-operativePost-operative

By Application

HospitalsSpecialty ClinicsAmbulatory Surgical Centers (ASCs)

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Pre-operative
3.1.3 Post-operative
3.1.4 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Hospitals
4.1.3 Specialty Clinics
4.1.4 Ambulatory Surgical Centers (ASCs)
4.1.5 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Stryker
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Zimmer Biomet
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 DePuy Synthes
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Materialise
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Brainlab AG
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Synopsys
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 medicAD Hectec GmbH
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 DePLy Synthes(Johnson &Johnson Medical Devices Companies)
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 CANONMEDICAL SISTEMSUSA INC
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 GeneralElectric Company
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Renishaw Plc
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 WishBone Medical
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 EchoPixel
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Intrasense
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Siemens
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Koninklijke Philips
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 RaySearch Laboratories
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 Renishaw
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 Brainlab
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)
8.20 Elekta
8.20.1 Company Overview
8.20.2 Key Products & Segments
8.20.3 Financial Performance (2023–2025)
8.20.4 Business Strategy
8.20.5 SWOT Analysis
8.20.6 Strategic Implications (2026–2032)
8.21 inomed Medizintechnik
8.21.1 Company Overview
8.21.2 Key Products & Segments
8.21.3 Financial Performance (2023–2025)
8.21.4 Business Strategy
8.21.5 SWOT Analysis
8.21.6 Strategic Implications (2026–2032)
8.22 Neurostar
8.22.1 Company Overview
8.22.2 Key Products & Segments
8.22.3 Financial Performance (2023–2025)
8.22.4 Business Strategy
8.22.5 SWOT Analysis
8.22.6 Strategic Implications (2026–2032)
8.23 Micromar
8.23.1 Company Overview
8.23.2 Key Products & Segments
8.23.3 Financial Performance (2023–2025)
8.23.4 Business Strategy
8.23.5 SWOT Analysis
8.23.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Surgical Planning Software market size?

The global Surgical Planning Software market is estimated at US$ 139 million in 2025 (base year) and is projected to reach US$ 212 million by 2032.

What growth rate is expected for the Surgical Planning Software market through 2032?

The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 139 million in 2025 to US$ 212 million in 2032, roughly 1.5 times its base-year value.

How is Surgical Planning Software defined?

How is the Surgical Planning Software market segmented by type?

By type, the market is segmented into Pre-operative and Post-operative.

What are the key applications of Surgical Planning Software?

Key applications covered include Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCs).

Which companies are profiled in the Surgical Planning Software market report?

Key players profiled include Stryker, Zimmer Biomet, DePuy Synthes, Materialise, Brainlab AG, Synopsys, medicAD Hectec GmbH and DePLy Synthes(Johnson &Johnson Medical Devices Companies), among 23 companies covered in total.

What geographies does the Surgical Planning Software market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the key demand drivers for Surgical Planning Software?

For example, the American Academy of Orthopedic Surgeons reported that over 1.7 million hip and knee replacements were performed in 2020, driving the surgical planning software market.

Who should buy the Surgical Planning Software market report?

The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCs), investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Surgical Planning Software market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.